Public Company

MAIA Biotechnology

About

MAIA Biotechnology, Inc. is a targeted therapy, immune-oncology company, focused on development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.

Overview

Founded 2018
Type Public
Location Chicago, Illinois, USA

Stock

MAIA $4.47 6.94% $0.29

Latest News

CalAmp And 2 Other Stocks Under $5 Insiders Are Aggressively Buying Dec 30, 2022 Benzinga The Dow Jones settled higher by over 300 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares,...
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday Aug 04, 2022 Benzinga Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume. ECMOHO Limited (NASDAQ: MOHO) jumped 146.1% to...
Why Poseida Therapeutics Almost Doubled Today, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session Aug 03, 2022 Benzinga Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday. Kaspien Holdings Inc. (NASDAQ: KSPN) gained 112.4% to...
This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket Aug 03, 2022 Benzinga Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday. Eargo, Inc. (NASDAQ: EAR) shares...
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday Aug 03, 2022 Benzinga Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks. Applied DNA Sciences, Inc. (NASDAQ:...